We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S.-Peru free-trade agreement (FTA) passed by the U.S. Congress will help promote access to affordable medicines, the generic pharmaceutical industry said.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor